Web-based Augmented Reality Solution for Novartis Oncology

Explore how MedTrix pioneered healthcare excellence through the world's first cutting-edge web augmented reality solution for patient engagement.

The Challenge

Novartis Oncology team in Switzerland was looking for an interactive solution for the brand Jakavi to engage and educate patients with myeloproliferative neoplasms (MPN) particularly polycythemia vera (PV). To meet this goal, they envisioned a mobile-friendly solution offering disease state information, Jakavi's treatment mode of action, useful links, and answers to frequently asked questions (FAQs).

Our Solution

We embraced the challenge of creating a cutting-edge patient engagement program using web-based Augmented Reality (AR) technology. This unique solution allowed users to experience AR directly through their mobile device's native browser, eliminating the need for app installation. To simplify user access, we used a unique code on Jakavi packaging to trigger the experience, eliminating the need for QR codes. Patients prescribed Jakavi could effortlessly access support materials by scanning the pack.

For FAQs, we integrated a sequential chat function, enabling users to access approved responses for common queries, along with suggested follow-up questions.

To cater to the Swiss market, the entire app content was thoughtfully developed in German, French, and Italian, with seamless language-switching during the user journey.

The Result

Through this collaboration with Novartis Oncology, MedTrix Healthcare pioneered the world's first web-based AR solution for patient engagement. Despite the rarity of the disease, the app's analytics revealed its active usage, indicating its valuable role in patient engagement. The continuous addition of features further exemplified the app's effectiveness in connecting with patients and meeting their needs.

The Recognitions

Client Testimonial